Admission for pain control for liver cancer. ICD-10-CM Codes: G89.3, C22.9 Malignant hypertension (think hypertension with kidney involvement) with stage 4 chronic kidney disease. ICD-10-CM Codes: I12.9, N18.4
The 2021 edition of ICD-10-CM G89.3 became effective on October 1, 2020. This is the American ICD-10-CM version of G89.3 - other international versions of ICD-10 G89.3 may differ. Applicable To. Cancer associated pain.
The guidelines are based on the coding and sequencing instructions from the Tabular List and the Alphabetic Index in ICD-10-CM. These guidelines are for medical coders who are assigning diagnosis codes in a hospital, outpatient setting, doctor’s office or some other patient setting.
ICD-10-CM Codes: G89.3, C22.9 Malignant hypertension (think hypertension with kidney involvement) with stage 4 chronic kidney disease. ICD-10-CM Codes: I12.9, N18.4
ICD-10 code G89. 3 for Neoplasm related pain (acute) (chronic) is a medical classification as listed by WHO under the range - Diseases of the nervous system .
Code 338.3 is used to classify pain related to, associated with, or due to a tumor or cancer whether primary or secondary. This code is used as the principal code when the admission or encounter is for pain control or pain management.
Code G89. 29 (Other chronic pain) is assigned as a secondary diagnosis. Category G89 contains codes for acute (G89. 11) and chronic (G89.
ICD-10-CM Code for Malignant neoplasm of liver, primary, unspecified as to type C22. 8.
89.29 or the diagnosis term “chronic pain syndrome” to utilize ICD-10 code G89. 4.
Neoplasm Related Pain Code G89. 3 is assigned to pain documented as being related, associated or due to cancer, primary or secondary malignancy, or tumor. This code is assigned regardless of whether the pain is acute or chronic.
Pain Management - Trigger Point Injections - CPT codes 20552 and 20553.
ICD-10 code Z98. 890 for Other specified postprocedural states is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
If liver cancer is documented with no further specification stating primary or secondary, assign code 155.2. It is appropriate to query the physician for clarification if the cancer is not specified as primary or metastatic. Benign neoplasm of the liver is assigned to code 211.5.
ICD-10 code: C78. 7 Secondary malignant neoplasm of liver and intrahepatic bile duct.
7 for Secondary malignant neoplasm of liver and intrahepatic bile duct is a medical classification as listed by WHO under the range - Malignant neoplasms .
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
When an encounter is for a pathological fracture due to a neoplasm, and the focus of treatment is the fracture, a code from subcategory M84.5, Pathological fracture in neoplastic disease, should be sequenced first, followed by the code for the neoplasm.
When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .